LIVN vs. PEN, STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, WRBY, and INSP
Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.
LivaNova vs. Its Competitors
LivaNova (NASDAQ:LIVN) and Penumbra (NYSE:PEN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.
LivaNova has higher revenue and earnings than Penumbra. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.
LivaNova has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500.
LivaNova currently has a consensus target price of $59.71, indicating a potential upside of 7.69%. Penumbra has a consensus target price of $300.47, indicating a potential upside of 10.71%. Given Penumbra's higher probable upside, analysts plainly believe Penumbra is more favorable than LivaNova.
Penumbra has a net margin of 11.54% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Penumbra's return on equity.
In the previous week, Penumbra had 5 more articles in the media than LivaNova. MarketBeat recorded 17 mentions for Penumbra and 12 mentions for LivaNova. LivaNova's average media sentiment score of 1.24 beat Penumbra's score of 0.85 indicating that LivaNova is being referred to more favorably in the media.
97.6% of LivaNova shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 0.3% of LivaNova shares are owned by company insiders. Comparatively, 4.2% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Penumbra beats LivaNova on 10 of the 17 factors compared between the two stocks.
Get LivaNova News Delivered to You Automatically
Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
LivaNova Competitors List
Related Companies and Tools
This page (NASDAQ:LIVN) was last updated on 8/28/2025 by MarketBeat.com Staff